Allogene Therapeutics (NASDAQ:ALLO) Q3 2026 Earnings Call
Allogene Therapeutics (NASDAQ:ALLO) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
- Company
- Allogene Therapeutics, Inc. (NASDAQ:ALLO)
- Period
- Q3 2026 earnings call
- Date
- Thu, Nov 5, 2026, 5:00 PM ET
- Results news release
- Allogene Highlights Clinical Progress and Next-Generation Innovation Across Its Off-the-Shelf CAR T Platform at SITC Annual Meeting · Tue, Nov 3, 2026
On 6ix: 6ix.com/event/allogene-therapeutics-inc-allo-q3-2026-earnings-call
Latest news releases
- NASDAQ:ALLO — Allogene Highlights Clinical Progress and Next-Generation Innovation Across Its Off-the-Shelf CAR T Platform at SITC Annual Meeting · Tue, Nov 3, 2026
- NASDAQ:ALLO — Allogene Therapeutics Announces November Investor Events Highlighting Q3 Results and Initial ALLO-329 Autoimmune Clinical Data · Thu, Oct 29, 2026